Skip to main content

Evofem Biosciences, Inc.

corporate_fare Company Profile

Evofem Biosciences, Inc.

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. The company's commercial products include PHEXXI, a vaginal gel for the prevention of pregnancy; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.

Exchange: OTCSector: Life Sciences

show_chartPrice Chart

Loading chart...

feed EVFM - Latest Insights

EVFM
Apr 16, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
EVFM
Mar 19, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
EVFM
Mar 11, 2026, 6:34 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
EVFM
Mar 11, 2026, 4:43 PM EDT
Filing Type: 10-K
Importance Score:
9
EVFM
Jan 12, 2026, 5:01 PM EST
Filing Type: 8-K
Importance Score:
8